Skip to main content
Neil Shneider, MD, Neurology, New York, NY, New York-Presbyterian Hospital

NeilAlanShneiderMDPhD

Neurology • New York, NY

Neuromuscular Medicine

The Claire Tow Associate Professor of Motor Neuron Disorders and Director, The Eleanor and Lou Gehrig ALS Center at Columbia University

Request Appointment

Overview of Dr. Shneider

Dr. Neil Shneider is a neurologist in New York, NY and is affiliated with multiple hospitals in the area, including New York-Presbyterian Hospital, NewYork-Presbyterian/Columbia University Irving Medical Center, Kessler Institute for Rehabilitation, and NYU Langone Hospitals. He received his medical degree from Columbia University Vagelos College of Physicians and Surgeons and has been in practice 23 years. Dr. Shneider accepts several types of health insurance, listed below. He is one of 474 doctors at New York-Presbyterian Hospital and one of 209 doctors at NewYork-Presbyterian/Columbia University Irving Medical Center who specialize in Neurology. He has more than 40 publications and over 500 citings.

Education & Training

  • Brigham and Women's Hospital/Massachusetts General Hospital/Harvard Medical School
    Brigham and Women's Hospital/Massachusetts General Hospital/Harvard Medical SchoolResidency, Neurology, 1995 - 1998
  • Beth Israel Deaconess Medical Center
    Beth Israel Deaconess Medical CenterInternship, Internal Medicine, 1994 - 1995
  • Columbia University Vagelos College of Physicians and Surgeons
    Columbia University Vagelos College of Physicians and SurgeonsClass of 1994

Certifications & Licensure

  • FL State Medical License
    FL State Medical License 2021 - Present
  • NY State Medical License
    NY State Medical License 1998 - 2025
  • MD State Medical License
    MD State Medical License 2002 - 2009
  • DC State Medical License
    DC State Medical License 2002 - 2004
  • MA State Medical License
    MA State Medical License 1997 - 1998

Publications & Presentations

PubMed

Press Mentions

  • Cellenkos Receives FDA Clearance of Investigational New Drug (IND) Application for CK0803 for the Treatment of Amyotrophic Lateral Sclerosis (ALS)
    Cellenkos Receives FDA Clearance of Investigational New Drug (IND) Application for CK0803 for the Treatment of Amyotrophic Lateral Sclerosis (ALS)September 22nd, 2022
  • New Initiative to Develop Personalized Therapies for People with Rare Genetic Forms of ALS
    New Initiative to Develop Personalized Therapies for People with Rare Genetic Forms of ALSMay 10th, 2022
  • N-lorem Foundation and Columbia University Establish Silence ALS Initiative
    N-lorem Foundation and Columbia University Establish Silence ALS InitiativeMay 3rd, 2022
  • Join now to see all

Grant Support

  • FUS/TLS GAIN AND LOSS OF FUNCTION IN ALS: ANIMAL AND CELLULAR MODELS OF DISEASENational Institute of Neurological Disorders and Stroke2011–2016

Hospital Affiliations

Insurance Accepted

  • Aetna Choice POS II
    Aetna HMO
    Anthem Blue Access Choice PPO
    Anthem Blue Access PPO
    BCBS Blue Card PPO
    CIGNA HMO
    CIGNA Open Access
    CIGNA PPO
    Coventry Health Care PPO Platinum
    Coventry Missouri - HMO/POS
    Empire BCBS HMO
    Empire BCBS PPO
    First Health PPO
    Great West PPO
    HealthLink PPO
    HIP of New York - Select PPO
    Humana ChoiceCare Network PPO
    Multiplan PHCS PPO
    Multiplan PPO
    MVP Healthcare PPO
    Oxford Health Freedom
    Oxford Health Liberty
    United Healthcare - Direct Choice Plus POS
    United Healthcare - Direct Options PPO
  • Please verify your coverage with the provider's office directly when scheduling an appointment

Dr. Neil Shneider, Dr. Neil Shneider, MD, Dr. N Shneider, Dr. Neil Alan Shneider